Prospective registry study of primary dyslipidemia
Not Applicable
Recruiting
- Conditions
- Homozygous familial hypercholesterolemia (homo-FH) Heterozygous familial hypercholesterolemia (hetero-FH) Type III Hyperlipoproteinemia Familial chylomicronemia Sitosterolemia Cerebrotendinous xanthomatosis Lecithin cholesterol acyltransferase (LCAT) deficiency Tangier disease Abetalipoproteinemia
- Registration Number
- JPRN-UMIN000042782
- Lead Sponsor
- ational Cerebral and Cardiovascular Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who refused to consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of adverse outcomes in patients with primary dyslipidemia [Through study completion]
- Secondary Outcome Measures
Name Time Method All-cause mortality [Through study completion]